Business Wire

L&T Technology Services inaugurates Digital Manufacturing and Electrification Prototype centers in Peoria, USA

Share

L&T Technology Services Limited (BSE: 540115, NSE: LTTS), a global leading pure-play engineering services company, today announced the inauguration of two new design and prototyping centers in Peoria, Illinois, USA, to support the digital engineering programs of customers. The two centers of excellence (CoE) will complement the existing LTTS flagship design center in Peoria.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221117006220/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

L-R, Mr Bhanu Gopalam, LTTS; Mr Tim Graham, Caterpillar; Mr Joshua Wirth, John Deere, Mr Darin Morman, Collins Aerospace, Mr John Kahl, Mayor of East Peoria, Mr Amit Chadha, LTTS, Mr Pari Natarajan, Zinnov, Mr Robert Martin, LTTS (Photo: Business Wire)

The new centers- 1DigitalPlace and Electrification & Prototyping Center- will offer services in digital manufacturing and next-gen electrification solutions across the transportation, medical, and hi-tech domains.

The 1DigitalPlace Center of Excellence leverages next generation manufacturing technologies to enable customers redefine their product journeys – from concept development through launch. It will help drive innovative solutions across the digital manufacturing spectrum, in key areas including artificial intelligence (AI), robotics, 3D-vision systems, and connected machines. With a focus on delivering cutting-edge Manufacturing Execution Systems and enabling next-gen digital twins, the CoE’s turnkey offerings will combine insights from the voice of the customer with LTTS’ state-of-the-art design, simulation, proof of concept and prototyping capabilities.

The Electrification & Prototype center is a state-of-the-art turnkey design facility providing services across the value chain. Powered by the latest in production automation technologies, LTTS’ newest CoE is capable of enabling the entire spectrum from conception through schematics, to physical prototype harness development in HIL test benches. It is helping expand and deepen our industry-leading expertise across electrification, UAVs, marine engineering solutions, and autonomy for end-to-end support. The CoE’s rapid turnaround time, global engineering teams, ISO9001-certified quality and testing capabilities, and no Minimum Order Quantity requirement will help drive a significant reduction in customer lead times and deliver enhanced project outcomes.

The fundamental objective of setting up the new centers is to develop a strategically located team capable of designing, constructing, and implementing manufacturing, quality operations processes and systems. LTTS’ customers stand to benefit from an enhanced experience paradigm focused on next-gen manufacturing technologies. As part of the planned expansion of the Peoria design center, LTTS plans to hire more than 500 engineers over the next 36 months.

LTTS’ expanded Peoria engineering hub will serve as a platform to provide services for all embedded software and hardware-based solutions, besides enabling next-gen process analytics solutions leveraging the best of AI, ML, Preventive & Predictive Maintenance capabilities. The center will act as a hub to attract and hire local engineers to fulfill existing and future customer requirements.

The Electrification and Prototype Center was unveiled by Mr Tim Graham of Caterpillar, Mr Darin Morman of Collins Aerospace, Mr John Kahl – Mayor of East Peoria, Mr Pari Natarajan of Zinnov, Mr Amit Chadha, Mr Bhanu Gopalam and Mr Robert Martin of LTTS. The 1DigitalPlace was inaugurated by Mr T. D. Bhutia, Deputy Consul General, Consulate General of India, Chicago, Mr William Strnad of Polaris, Mr Rajeev Gupta, Mr Alind Saxena and Mr Rodney Duran of LTTS.

Commenting on the inauguration, Congressman Darin LaHood, U.S. Rep. for the State of Illinois said, “Our community is excited to hear the announcement by LTTS to expand in the City of Peoria, which will help further boost our technology ecosystem and also help create more jobs and opportunities in engineering and allied fields. Thank you for your investment in Central Illinois and promoting innovation and technology across our region.”

John Kahl, Mayor of East Peoriasaid, “It is heartening to see engineering and technology providers like LTTS setting up their base in Peoria and further cementing the region’s reputation as a technology and innovation hub. On behalf of the People of Peoria, I Congratulate LTTS on the establishment of the new digital centers and look forward to a fruitful engagement with them, benefiting the local economy and community.”

His Excellency Taranjit Singh Sandhu, Indian Ambassador to the United States commented, “I would like to congratulate L&T Technology Services for the new engineering facilities in Peoria, Illinois. This is an exciting moment for LTTS and the engineering & technology sector in Illinois. LTTS’ contributions in U.S. demonstrates the power of Indian companies to add value, competitiveness and skills in the US as well as enrich the local community. I wish LTTS all success!”

Amit Chadha, CEO & Managing Director, L&T Technology Services said, We have set-up ourtwo new facilities with an endeavor to serve our global clientele more closely located to their base locations. The center will leverage LTTS’ domain expertise in areas like Digital Manufacturing, Electrification and Sustainability and play a vital role in creation of new offerings, innovations and technologies for global customers.”

About L&T Technology Services Ltd

L&T Technology Services Limited (LTTS) is a listed subsidiary of Larsen & Toubro Limited focused on Engineering and R&D (ER&D) services. We offer consultancy, design, development and testing services across the product and process development life cycle. Our customer base includes 69 Fortune 500 companies and 57 of the world’s top ER&D companies, across industrial products, medical devices, transportation, telecom & hi-tech, and the process industries. Headquartered in India, we have over 21,400 employees spread across 20 global design centers, 28 global sales offices and 90 innovation labs as of September 30, 2022. For more information, please visit https://www.ltts.com/

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Aniruddha Basu
L&T Technology Services Limited
E: Aniruddha.Basu@LTTS.com
T: +91-80-67675707

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Datopotamab Deruxtecan Showed Encouraging and Durable Efficacy in Patients with Heavily Pretreated HR Positive, HER2 Low or Negative Metastatic Breast Cancer9.12.2022 00:00:00 CET | Press release

Initial results from the TROPION-PanTumor01 phase 1 trial of datopotamab deruxtecan (Dato-DXd) showed encouraging and durable efficacy in patients with heavily pretreated hormone receptor (HR) positive, HER2 low (immunohistochemistry [IHC] 1+ or IHC 2+/in-situ hybridization [ISH]-) or HER2 negative (IHC 0) unresectable or metastatic breast cancer. Safety data were consistent with previous trials of datopotamab deruxtecan. Results were presented today as a Spotlight Poster Discussion (Abstract #PD13-08) at the 2022 San Antonio Breast Cancer Symposium (#SABCS22). Datopotamab deruxtecan is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) being jointly developed by Daiichi Sankyo (TSE: 4568) and AstraZeneca (LSE/STO/Nasdaq: AZN). Approximately 70% of breast cancer tumors are considered HR positive and HER2 low or negative.1 For patients with HR positive, HER2 low or negative metastatic breast cancer that progress on or are not suitable candidates for endocrine the

TreviPay Acquires Apruve8.12.2022 23:45:00 CET | Press release

TreviPay, a leader in global B2B payments and invoicing solutions, today announced the signing of a definitive agreement to acquire payment platform Apruve. Apruve offers a robust suite of payment solutions for global enterprises that will complement and expand on TreviPay’s existing order-to-cash technology offerings, merchant invoicing solutions, and the geographical reach of TreviPay’s existing B2B networks. TreviPay has experienced unprecedented demand from global enterprise buyers and sellers resulting in 30% organic growth in 2022, and this acquisition furthers TreviPay's plans to expand its order-to-cash technology offerings and B2B payment network. This acquisition builds on TreviPay’s recent purchase of Baton Financial Services. “TreviPay provides payment and invoicing solutions for a number of leading manufacturers and OEMs; the acquisition of Apruve will accelerate our advancement in the technology manufacturing vertical and expand our geographic reach into key Asian markets

Ipsen Provides Update On Phase III CONTACT-01 Trial Evaluating Cabozantinib in Combination With Atezolizumab in Patients With Metastatic Non-small Cell Lung Cancer Previously Treated With Immunotherapy and Chemotherapy8.12.2022 22:05:00 CET | Press release

Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) announced today that the CONTACT-01 study did not meet its primary endpoint of overall survival (OS) at the final analysis. CONTACT-01 is a phase III clinical trial evaluating Cabometyx® (cabozantinib) in combination with atezolizumab (Tecentriq®) versus docetaxel in patients with unmutated metastatic non-small cell lung cancer (NSCLC) who experienced disease progression on or after treatment with an immune checkpoint inhibitor and platinum-containing chemotherapy. Howard Mayer, M.D., Executive Vice President, Head of Research and Development at Ipsen, said: “The results from the CONTACT-01 clinical trial have shown the challenge of treating NSCLC patients after prior lines of treatment have failed. While the findings of the study have not met the primary endpoint in this setting, we remain confident in the clinical efficacy of cabozantinib alone and in combination with another treatment in existing indications in difficult-to-treat tu

Verisign Reports Internet Has 349.9 Million Domain Name Registrations at the End of the Third Quarter of 20228.12.2022 21:57:00 CET | Press release

VeriSign, Inc. (NASDAQ: VRSN), a global provider of domain name registry services and internet infrastructure, today announced that the third quarter of 2022 closed with 349.9 million domain name registrations across all top-level domains, a decrease of 1.6 million domain name registrations, or 0.4%, compared to the second quarter of 2022.1,2 Domain name registrations have increased by 11.5 million, or 3.4%, year over year.1,2 The .com and .net TLDs had a combined total of 174.2 million domain name registrations in the domain name base3 at the end of the third quarter of 2022, a decrease of 0.2 million domain name registrations, or 0.1%, compared to the second quarter of 2022. The .com and .net TLDs had a combined increase of 2.1 million domain name registrations, or 1.2%, year over year. As of Sept. 30, 2022, the .com domain name base totaled 160.9 million domain name registrations, and the .net domain name base totaled 13.2 million domain name registrations. New .com and .net domain

Citi Global Wealth Investments Releases Outlook 2023: Roadmap to Recovery: Portfolios to Anticipate Opportunities8.12.2022 20:07:00 CET | Press release

Citi Global Wealth Investments (CGWI) today released its Wealth Outlook 2023 (Outlook) report, titled Roadmap to Recovery: Portfolios to Anticipate Opportunities. Published twice yearly, Outlook provides in-depth insights into the global economy and financial markets for the year ahead and beyond. The latest edition’s title reflects the investing journey that CGWI envisions and the steps that investors should consider diversifying their portfolios. In 2023, CGWI predicts the weakest annual global economic growth in forty years outside of the Global Financial Crisis and the COVID shutdowns. The year ahead is likely to see: A shallow US recession and worse in some other places such as the Eurozone A recovery in Chinese growth, by contrast, as pandemic restrictions are relaxed US inflation continuing to ease, ending 2023 at around 3.5% The US Federal Reserve to start cutting interest rates by the second half of the year A 10% drop in global earnings per share Just as 2022’s global market